EVIO, Inc. (EVIO) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開. 本社所在地は Henderson, NV, アメリカ. 現CEOは Lori Jean Glauser.
EVIO を有する IPO日 2004-01-21, 18 名の正社員, に上場 Other OTC, 時価総額 $1.92M.
EVIO, Inc., together with its subsidiaries, provides analytical testing and advisory services to cannabis industry in the United States. The company's consulting services include advisory, product formulation, and licensing and compliance services. It also offers various testing services comprise cannabinoid potency testing, terpene analysis, pesticide testing, residual solvent screening, visual inspections, biological contaminant testing, and other services. EVIO, Inc. is headquartered in Henderson, Nevada.
